Antibacterial textiles are undergoing an invisible 'standard upgrade war.' In June, the national standard review meeting for the absorption method of antibacterial textile evaluation was held in Zhejiang. This was not a routine technical meeting but a critical milestone in the revision of the GB/T 20944 series—old standards have served for nearly two decades, while antibacterial technologies, materials, and testing methods have evolved multiple times. The lagging standards have long needed to address market chaos.
Background
The GB/T 20944 series consists of three parts: the agar diffusion method, the absorption method, and the shaking method. Since their release between 2007 and 2008, they have served as the 'basic law' for antibacterial textile evaluation. However, applications have expanded from underwear and socks to sportswear, medical textiles, and home soft furnishings. Antibacterial agents have also progressed from silver ions and chitosan to photocatalytic and nanomaterial systems. Testing instruments and laboratory capabilities have improved substantially, making old test conditions and thresholds increasingly detached from industrial reality.
The revision is advancing on two tracks: the shaking method (Part 3) was tasked in June 2024 and is now in the approval stage; the absorption method (Part 2) was tasked in June 2025, with the Zhejiang review marking substantive progress. Both standards will fully replace the 2007 and 2008 versions. Drafting units include testing institutions, research institutes, brand companies, and new material enterprises, reflecting broad industry participation.
Industry Impact
For manufacturers, the revision means that the 'antibacterial' label can no longer be a marketing gimmick. Previously, some companies exploited limitations in old test methods to mislead consumers with vague data or exaggerated claims. If the new standard adopts test methods closer to real usage scenarios, it will directly raise testing thresholds, forcing brands lacking technical reserves to exit. For buyers, the upgrade helps build more credible supplier evaluation systems, reducing return and legal risks caused by substandard antibacterial performance.
More deeply, the revision signals a regulatory orientation toward 'scientific evaluation.' Antibacterial properties are invisible and intangible; consumers rely solely on test reports. If test methods are inconsistent and indicators are not rigorous, the market can easily fall into a 'bad money drives out good' cycle. The new standard enhances accuracy and repeatability, providing a basis for differentiation for quality products and offering technical support for foreign trade companies facing increasingly stringent international antibacterial requirements.
